Flow cytometry (FCM) has been used to measure intracellular Adriamycin (ADM) in cells cultured in monolayer (Bhuyan et al., 1981 , Durand & Olive, 1981 , Ganapathi et al., 1982 , suspension cultures (Durand & Olive, 1981 , Ganapathi et al., 1982 , Krishan & Ganapathi, 1980 , Sutherland et al., 1979 and in spheroids (Durand, 1981) . We have used FCM and cell survival assays to investigate the response of exponentially growing and plateau phase monolayer EMT6 cultures to ADM.
Flow cytometry (FCM) has been used to measure intracellular Adriamycin (ADM) in cells cultured in monolayer (Bhuyan et al., 1981 , Durand & Olive, 1981 , Ganapathi et al., 1982 , suspension cultures (Durand & Olive, 1981 , Ganapathi et al., 1982 , Krishan & Ganapathi, 1980 , Sutherland et al., 1979 and in spheroids (Durand, 1981) . We have used FCM and cell survival assays to investigate the response of exponentially growing and plateau phase monolayer EMT6 cultures to ADM.
A number of problems are associated with FCM measurement of ADM fluorescence (Durand & Olive, 1981) and two particular problems are encountered when attempting to compare exponentially growing and plateau phase cells. The first is that exponential and plateau phase cultures have different monolayer densities. The second is whether FCM measurement of ADM fluorescence from exponentially growing and plateau phase EMT6 cells are quantitatively comparable. Durand (1981) has mentioned that cell density may effect cytotoxicity; we have investigated the effect of cell density on the amount of ADM measured in the cell after treatment. Sutherland et al. (1979) Cell culture The cells used in all experiments were EMT6/CC details of which have previously been published Estimation of relative adriamycin uptake A detailed account of the extraction method was published by Schwartz (1973) . Briefly, 105 cells from each sample were centrifuged at 200 g for 5 min at room temperature, the medium was removed and 0.2ml of 0.1% solution of ice cold sodium lauryl sulphate (BDH Chemicals) was added. The mixture was pipetted to lyse the cells and 0.2ml of ice cold silver nitrate solution (33% w/v) added. The samples were then shaken vigorously for 10min at 4°C using a Gallankemp flask shaker. Four ml of ice cold isoamyl alcohol were added to each sample and the samples shaken for a further 10 min. The extracts were centrifuged at 200 g for 5 min at room temperature and the isoamyl alcohol fraction was carefully removed with a pasteur pipette.
ADM fluorescence from the extracts was measured using an MPF-4 Perkin Elmer fluorimeter with excitation at 490 nm and analysis between 575 and 595 nm. FCM analysis was carried out on the flow cytometer constructed in these laboratories (Watson, 1980) (Schwartz, 1973) . In order to establish that FCM and extraction will give a similar relationship between exponentially growing and plateau phase cells the two techniques were run in parallel.
Exponentially growing and plateau phase cells were prepared as described above. The growth medium was removed and 5ml of fresh medium containing ADM at concentrations of 0, 1, 2, 5, 10, 25 ugADM ml-1 were added to the cells. Incubation was for 1 h at 37°C. The cells were then trypsinised and resuspended in 5ml of medium, 105 cells were removed from each sample for extraction of ADM and the remainder were analysed for ADM by FCM.
Isodose experiments Experiments were designed to expose exponentially growing and plateau phase cells to the same dose range of ADM in terms of picograms (pg) per cell.
Exponentially growing and plateau phase cultures were prepared as described previously. Plateau cells were treated with doses of 0, 1.25, 2.5, 3.75, 6.25 pg per cell, exponentially growing cells were treated with 0, 0.5, 1, 2, 3, 4pg per cell. The cultures were incubated for 1 h at 37°C and then assayed for surviving fraction and ADM content by FCM analysis as described above. However, when ADM drug levels were expressed as the intracellular ADM concentration assayed by FCM, it was apparent that the reverse was true ( Figure 4) exponentially growing and plateau phase CHO cells with between 0 and lOg ADM ml-1 of growth medium. Their conclusions were that plateau phase cells had the same shape survival curve as exponentially growing cells but were less sensitive to ADM. They made no allowance for the difference in cell density between the two proliferative states. published results from the investigation of the response of EMT6 exponentially growing and plateau phase cells to ADM. They used the convention of presenting surviving fraction plotted against the concentration of the drug in the medium and commented that differences in observed response may be due to drug availability. However, no experiments were carried out to investigate whether or not this was true. We have shown that there is indeed an effect due to drug availability and cell density. Data in Figure 1 show that at ADM doses generally used (0-5pgADMml-1) in experiments when treating cells in vitro, the cell number can be an important factor in determining the clonogenic fraction; 2.5 x 105 cells ml-' gave a surviving fraction of 0.025 whereas 106 cells ml-l gave a surviving fraction of 0.2, a difference of one decade, when treated with medium containing 2 ug ml-1 ADM. When attempting to compare the sensitivities of clonogenic cells in monolayers of exponentially growing and plateau phase cultures, where the cell number present in the latter culture is at least one hundred times that of the former we now believe that it is important to take into account the effect of cell number in relationship to drug dose. Durand & Olive (1981) Having established how best to represent our results and that FCM was giving a fair comparison of ADM levels in exponentially growing and plateau phase cells, we were able to draw some conclusions as to the response of the cells in these two proliferative states to ADM.
Results
A similar range of exposure doses were given to both exponentially growing and plateau phase cells. Figure 3 indicates plateau phase cells were more sensitive over the dose range 0-10pg per 106 cells. Figure 5 shows that over that dose range a greater quantity of ADM was taken up by plateau phase cells. This indicates plateau phase cells have a far greater ability to accumulate ADM than exponentially growing cells but are less sensitive to a change in internal drug concentration. This point is demonstrated in Figure 4 where, for a given amount of internal ADM, plateau phase cells are far less sensitive than exponentially growing cells and the slope of their survival curve considerably less than that for exponentially growing cells.
Our results agree with the findings of Bhuyan et al. (1981) in that intracellular drug concentration may not account for the sensitivity of the cells to a (1979) over the range of dose of ADM that was used. The differences in ADM uptake found in exponentially growing cells and plateau phase cells are likely to be primarily due to differences in the membrane permeability/drug export in the two proliferative states. Cell membrane differences have been shown to alter the uptake of ADM (Li & Hahn, 1978) and these data would suggest that plateau phase cells have more permeable membranes than exponentially growing cells.
The observation that, for a given amount of intracellular ADM, exponentially growing cells were far more sensitive to ADM is less easy to explain. We have demonstrated that the toxicity of ADM is not due simply to the total amount of ADM associated with the cell, therefore the ADM must be acting on a sensitive target that is preferentially expressed by exponentially growing cells, but not plateau phase cells. ADM is thought to act on several different sites within the cell (Bachur, 1975) and we have preliminary data suggesting that up to 45% of the ADM fluorescence for exponentially growing cells is associated with RNA (Smith and Chambers, unpublished data). Since exponentially growing cells have more RNA than plateau phase cells (Watson & Chambers, 1977) , it is possible that the RNA content may play a role in ADM cytotoxicity. Tritton (1982) has shown that the cell surface may be an important site for the cytotoxic action of ADM. If this is so the ratio of cell number to drug concentration will still be a factor in determining cell survival. However he does not rule out that the administration of free ADM affects cell viability through DNA intercalation. We have shown that in this case it is important to measure intracellular ADM concentrations in order to draw conclusions as to the relative sensitivities of cells to the drug.
